Home Medicine Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves’ disease
Article
Licensed
Unlicensed Requires Authentication

Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves’ disease

  • Reuven Zev Cohen EMAIL logo , Eric I. Felner , Kurt F. Heiss , J. Bradley Wyly and Andrew B. Muir
Published/Copyright: December 10, 2015

Abstract

Background: The majority of pediatric patients with Graves’ disease will ultimately require definitive therapy in the form of radioactive iodine (RAI) ablation or thyroidectomy. There are few studies that directly compare the efficacy and complication rates between RAI and thyroidectomy. We compared the relapse rate as well as the acute and long-term complications of RAI and total thyroidectomy among children and adolescents with Graves’ disease treated at our center.

Methods: Medical records from 81 children and adolescents with a diagnosis of Graves’ disease who received definitive therapy over a 12-year period were reviewed.

Results: Fifty one patients received RAI and 30 patients underwent thyroidectomy. The relapse rate was not significantly different between RAI and thyroidectomy (12.1% vs. 0.0%, p=0.28). There were no acute or long-term complications in the RAI group, but there were eight cases of hypoparathyroidism (two transient and six permanent) in the thyroidectomy group. None of the patients developed a recurrent laryngeal nerve injury.

Conclusions: RAI is a safe and effective option for treatment of children and adolescents with Graves’ disease. In light of the rate of permanent hypoparathyroidism seen at our center with thyroidectomy and previously published long-term safety of RAI, we recommend RAI as the first line treatment for children and adolescents with Graves’ disease. For those centers performing thyroidectomies, we recommend that each center select 1–2 high-volume pediatric surgeons to perform all thyroid procedures, allowing individuals to increases case volume and potentially decrease long-term complications of thyroidectomy.


Corresponding author: Reuven Zev Cohen, Department of Pediatrics, Emory University School of Medicine Atlanta, 2015 Upper Gate Dr., Atlanta, GA 30322, USA, E-mail:

Acknowledgments

We gratefully acknowledge the assistance of Prabhu Shankar, MD (Childrens’ Healthcare of Atlanta) in the facilitation of this study.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Hepatic Toxicity Following Treatment for Pediatric Graves’ Disease Meeting 2008; Rockville, MD, 2009.Search in Google Scholar

2. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011;21:593–646.10.1089/thy.2010.0417Search in Google Scholar PubMed

3. Rivkees SA. The treatment of Graves’ disease in children. J Pediatr Endocr Met 2006;19:1095–111.10.1515/JPEM.2006.19.9.1095Search in Google Scholar

4. Rivkees SA, Stephenson K, Dinauer C. Adverse events associated with methimazole therapy of graves’ disease in children. Int J Pediatr Endocrinol 2010;2010:176970.10.1186/1687-9856-2010-176970Search in Google Scholar

5. Rivkees SA, Cornelius EA. Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics 2003;111(4 Pt 1):745–9.10.1542/peds.111.4.745Search in Google Scholar PubMed

6. Boice JD, Jr. Radiation and thyroid cancer: what more can be learned? Acta Oncologica 1998;37:321–4.10.1080/028418698430520Search in Google Scholar PubMed

7. Read CH, Jr, Tansey MJ, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves’ patients. J Clin Endocr Metab 2004;89:4229–33.10.1210/jc.2003-031223Search in Google Scholar PubMed

8. Nebesio TD, Siddiqui AR, Pescovitz OH, Eugster EA. Time course to hypothyroidism after fixed-dose radioablation therapy of Graves’ disease in children. J Pediatr 2002;141:99–103.10.1067/mpd.2002.125494Search in Google Scholar PubMed

9. Levy WJ, Schumacher OP, Gupta M. Treatment of childhood Graves’ disease. A review with emphasis on radioiodine treatment. Clev Clin J Med 1988;55:373–82.10.3949/ccjm.55.4.373Search in Google Scholar PubMed

10. Kadmon PM, Noto RB, Boney CM, Goodwin G, Gruppuso PA. Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication. J Clin Endocr Metab 2001;86:1865–7.10.1210/jcem.86.5.7473Search in Google Scholar PubMed

11. Rivkees SA, Sklar C, Freemark M. Clinical review 99: the management of Graves’ disease in children, with special emphasis on radioiodine treatment. J Clin Endocr Metab 1998;83:3767–76.Search in Google Scholar

12. Sosa JA, Tuggle CT, Wang TS, Thomas DC, Boudourakis L, et al. Clinical and economic outcomes of thyroid and parathyroid surgery in children. J Clin Endocr Metab 2008;93:3058–65.10.1210/jc.2008-0660Search in Google Scholar PubMed

13. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Radioiodine therapy of Graves’ hyperthyroidism: standard vs. calculated 131iodine activity. Results from a prospective, randomized, multicentre study. Eur J Clin Invest 1995;25:186–93.10.1111/j.1365-2362.1995.tb01547.xSearch in Google Scholar PubMed

14. Glaser NS, Styne DM. Predictors of early remission of hyperthyroidism in children. J Clin Endocr Metab 1997;82: 1719–26.Search in Google Scholar

15. Hamburger JI. Management of hyperthyroidism in children and adolescents. J Clin Endocr Metab 1985;60:1019–24.10.1210/jcem-60-5-1019Search in Google Scholar PubMed

16. Dunn JT. Choice of therapy in young adults with hyperthyroidism of Graves’ disease. A brief, case-directed poll of fifty-four thyroidologists. Ann Intern Med 1984;100:891–3.10.7326/0003-4819-100-6-891Search in Google Scholar PubMed

17. West JD, Cheetham TD, Dane C, Natarajan A. Should radioiodine be the first-line treatment for paediatric Graves’ disease? J Pediatr Endocr Met 2015;28:797–804.10.1515/jpem-2014-0176Search in Google Scholar PubMed

Received: 2015-8-18
Accepted: 2015-11-2
Published Online: 2015-12-10
Published in Print: 2016-3-1

©2016 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Role of nutrition in preventing insulin resistance in children
  4. Original Articles
  5. Reduced frequency and severity of ketoacidosis at diagnosis of childhood type 1 diabetes in Northwest Saudi Arabia
  6. Differences in parental involvement in the care of children and adolescents with type 1 diabetes mellitus on multiple daily insulin injections versus continuous subcutaneous insulin infusion
  7. Value of the intrarenal arterial resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients
  8. Remission of congenital hyperinsulinism following conservative treatment: an exploratory study in patients with KATP channel mutations
  9. Relationship between visceral obesity and plasma fibrinogen in obese children
  10. Diagnostic approach in children with unusual symptoms of acquired hypothyroidism. When to look for pituitary hyperplasia?
  11. The shortened combined clonidine and arginine test for growth hormone deficiency is practical and specific: a diagnostic accuracy study
  12. Bone maturation along the spectrum from normal weight to obesity: a complex interplay of sex, growth factors and weight gain
  13. Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves’ disease
  14. Direct sequencing of FAH gene in Pakistani tyrosinemia type 1 families reveals a novel mutation
  15. Odontoiatric perspectives and osteonecrosis of the jaw as a possible adverse effect of bisphosphonates therapy in fibrous dysplasia and McCune-Albright syndrome
  16. The relation of urinary bisphenol A with kisspeptin in girls diagnosed with central precocious puberty and premature thelarche
  17. Pattern of teen menstruation among secondary school girls in south east Nigeria
  18. Should children with isolated premature adrenarche be routinely evaluated for non-classical congenital adrenal hyperplasia?
  19. Anxiety, depression and self-esteem levels in obese children: a case-control study
  20. Case Reports
  21. Transient congenital hypothyroidism caused by compound heterozygous mutations affecting the NADPH-oxidase domain of DUOX2
  22. Isolated methylmalonic acidemia with unusual presentation mimicking diabetic ketoacidosis
  23. A first case report of UDP-galactose-4′-epimerase deficiency in China: genotype and phenotype
  24. A novel mutation in the glutamate dehydrogenase (GLUD1) of a patient with congenital hyperinsulinism-hyperammonemia (HI/HA)
  25. Letter to the Editor
  26. Partial biotinidase deficiency: identification of a single novel mutation (p.H314R) in a Greek newborn
Downloaded on 18.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0333/pdf
Scroll to top button